{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-123359","form_type":"8-K","ticker":"TKNO","cik":"0001850902","company_name":"Alpha Teknova, Inc.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.050595+00:00","generated_at":"2026-05-30T03:51:38.381990+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Teknova Q3 revenue up 17% to $9.6M; net loss $7.6M; guidance reiterates $35-38M","bullets":["Total revenue $9.6M (+17% YoY); Clinical Solutions up 229% to $2.0M; Lab Essentials flat at $7.2M.","GAAP net loss $7.6M ($0.15 EPS); adjusted EBITDA negative $5.0M; excludes $2.8M non-cash inventory charge.","Gross margin 0.9% (29.8% excluding $2.8M charge) vs 18.0% in Q3 2023.","Operating expenses down to $7.5M from $10.2M YoY, driven by reduced headcount and professional fees.","2024 free cash outflow outlook lowered to <$16M from <$18M; revenue guidance reaffirmed at $35-38M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-123359","json":"https://secwatch.observer/filing/0000950170-24-123359.json","markdown":"https://secwatch.observer/filing/0000950170-24-123359.md","text":"https://secwatch.observer/filing/0000950170-24-123359.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850902/000095017024123359/0000950170-24-123359-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850902/000095017024123359/tkno-20241107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:51:38.381990+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}